Abstract
Chronic cerebrospinal venous insufficiency (CCSVI) was recently proposed as a contributing factor in the pathology of multiple sclerosis. This concept has gained remarkable attention, partly because endovascular neurointervention has been suggested as a treatment strategy. This review summarizes available evidence and provides a critical analysis of the published data. Currently, there is inconclusive evidence to support CCSVI as an etiological factor in patients with multiple sclerosis. Endovascular procedures should not be undertaken outside of controlled clinical trials.
Original language | English (US) |
---|---|
Pages (from-to) | 231-235 |
Number of pages | 5 |
Journal | Therapeutic Advances in Neurological Disorders |
Volume | 4 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2011 |
Keywords
- chronic cerebrospinal venous insufficiency
- multiple sclerosis
ASJC Scopus subject areas
- Pharmacology
- Neurology
- Clinical Neurology